Clinical Trial Update: The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of Methylene Blue MMX Modified Release Tablets in subjects undergoing screening or surveillance colonoscopy for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Methylene blue MMX Modified Release Tablets (methylene blue)

Snippet

Sponsor: Cosmo Technologies Ltd | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-11-06